Bank of Montreal’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-21,968
| Closed | -$1.02M | – | 5162 |
|
|
2019
Q2 | $1.02M | Buy |
21,968
+18,401
| +516% | +$517K | ﹤0.01% | 2057 |
|
|
2019
Q1 | $87K | Sell |
3,567
-2,312
| -39% | -$48.1K | ﹤0.01% | 3125 |
|
|
2018
Q4 | $83K | Buy |
5,879
+1,888
| +47% | +$28.6K | ﹤0.01% | 3050 |
|
|
2018
Q3 | $60K | Sell |
3,991
-52
| -1% | -$797 | ﹤0.01% | 3315 |
|
|
2018
Q2 | $67K | Buy |
4,043
+1,535
| +61% | +$24.4K | ﹤0.01% | 3305 |
|
|
2018
Q1 | $41K | Hold |
2,508
| – | – | ﹤0.01% | 3314 |
|
|
2017
Q4 | $32K | Buy |
2,508
+1,000
| +66% | +$11.4K | ﹤0.01% | 3437 |
|
|
2017
Q3 | $19K | Sell |
1,508
-162,900
| -99% | -$1.51M | ﹤0.01% | 3543 |
|
|
2017
Q2 | $1.38M | Buy |
164,408
+162,900
| +10,802% | +$1.33M | ﹤0.01% | 1834 |
|
|
2017
Q1 | $13K | Hold |
1,508
| – | – | ﹤0.01% | 3489 |
|
|
2016
Q4 | $12K | Buy |
1,508
+1,113
| +282% | +$8.19K | ﹤0.01% | 3547 |
|
|
2016
Q3 | $3K | Hold |
395
| – | – | ﹤0.01% | 3825 |
|
|
2016
Q2 | $1K | Sell |
395
-395
| -50% | -$1.29K | ﹤0.01% | 4024 |
|
|
2016
Q1 | $2K | Hold |
790
| – | – | ﹤0.01% | 4003 |
|
|
2015
Q4 | $3K | Buy |
+790
| New | +$3.6K | ﹤0.01% | 3933 |
|
|
2014
Q3 | – | Sell |
-3,110
| Closed | -$14K | – | 4612 |
|
|
2014
Q2 | $14K | Buy |
+3,110
| New | +$12.9K | ﹤0.01% | 3747 |
|
Other funds holding ARRY
Bank of Montreal's ARRY Position: Q3 2019 in Review
Bank of Montreal sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 21,968 shares — an estimated $1.02M sold.
Bank of Montreal first reported a position in ARRY in Q2 2014 and held it in 16 quarters. The position peaked at $1.38M in Q2 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Bank of Montreal reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Bank of Montreal sold 21,968 Array Biopharma Inc shares in Q3 2019, an estimated $1.02M.
- Bank of Montreal first reported a position in Array Biopharma Inc in Q2 2014 and held it in 16 quarters.
- Bank of Montreal's Array Biopharma Inc position peaked at $1.38M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Bank of Montreal's 13F filing for Q3 2019, filed 8 Nov 2019.